Literature DB >> 4597703

In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

S Normark, J Schönebeck.   

Abstract

Spontaneous mutants of Candida albicans resistant to 5-fluorocytosine (5-FC) were isolated from a strain susceptible to 5-FC. These mutants were compared with 5-FC-resistant strains of C. albicans and Torulopsis glabrata isolated from patients treated with the drug and from untreated patients. Resistance to 5-FC was in all cases followed by a decreased susceptibility to 5-fluorouracil. Most strains were also more resistant to 5-fluorouridine and had a lowered incorporation of uridine. In one spontaneous mutant totally resistant to all three 5-fluoropyrimidines, the uridine monophosphate pyrophosphorylase activity was greatly decreased. The 5-FC-resistant strains were of two main phenotypic classes. Class one was unaffected by 5-FC at the highest concentration tested. The growth rate of strains belonging to the other class was markedly decreased by low concentrations of 5-FC, but these strains were still able to form colonies after 7 days of incubation on plates containing very high concentrations of the drug (2,000 mug/ml). The frequency of spontaneous mutation of a susceptible strain to 5-FC resistance was fairly high. The number of mutants growing on media containing 5-FC was unchanged by concentrations ranging from 25 to 500 mug/ml.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4597703      PMCID: PMC444277          DOI: 10.1128/AAC.2.3.114

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

2.  Acetylornithinase of Escherichia coli: partial purification and some properties.

Authors:  H J VOGEL; D M BONNER
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli.

Authors:  G BERTANI
Journal:  J Bacteriol       Date:  1951-09       Impact factor: 3.490

5.  5-fluorocytosine treatment of candida infections of the urinary tract and other sites.

Authors:  J Schönebeck; L Steen; A Tärnvik
Journal:  Scand J Urol Nephrol       Date:  1972

6.  The utilization of exogenous pyrimidines and the recycling of uridine-5'-phosphate derivatives in Saccharomyces cerevisiae, as studied by means of mutants affected in pyrimidine uptake and metabolism.

Authors:  M Grenson
Journal:  Eur J Biochem       Date:  1969-12

7.  [Oral antimycotic agent, 5-fluorocytosine].

Authors:  H J Scholer
Journal:  Mykosen       Date:  1970-04-01

8.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

9.  Further in vitro studies with 5-fluorocytosine.

Authors:  S Shadomy
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

10.  The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man.

Authors:  B A Koechlin; F Rubio; S Palmer; T Gabriel; R Duschinsky
Journal:  Biochem Pharmacol       Date:  1966-04       Impact factor: 5.858

View more
  25 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  New antifungal therapy in ophthalmology.

Authors:  T W Lieberman; I H Leopold
Journal:  Trans Am Ophthalmol Soc       Date:  1973

Review 3.  Antifungal adjuvants: Preserving and extending the antifungal arsenal.

Authors:  Arielle Butts; Glen E Palmer; P David Rogers
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

4.  Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.

Authors:  R L Kaspar; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

5.  Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.

Authors:  K S Defever; W L Whelan; A L Rogers; E S Beneke; J M Veselenak; D R Soll
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

6.  Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.

Authors:  W L Whelan; D Kerridge
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

7.  Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.

Authors:  J Schönebeck; E Segerbrand
Journal:  Br Med J       Date:  1973-11-10

8.  Molecular mechanisms of resistance to 5-fluorocytosine in laboratory mutants of Candida glabrata.

Authors:  Patrick Vandeputte; Laurent Pineau; Gérald Larcher; Thierry Noel; Daniel Brèthes; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2010-07-09       Impact factor: 2.574

9.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

Review 10.  Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.

Authors:  B D Alexander; J R Perfect
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.